International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the …
Summary Patient-reported outcomes (PROs), such as symptoms, function, and other health-
related quality-of-life aspects, are increasingly evaluated in cancer randomised controlled …
related quality-of-life aspects, are increasingly evaluated in cancer randomised controlled …
[PDF][PDF] International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials
C Coens, M Pe, AC Dueck, J Sloan, E Basch, M Calvert… - pure-oai.bham.ac.uk
EORTC received an unrestricted education grant from Boehringer Ingelheim GmbH 90 to
initiate this work and from Genentech, a member of the Roche Group, for 91 continuity …
initiate this work and from Genentech, a member of the Roche Group, for 91 continuity …
[PDF][PDF] International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the …
Lancet Oncol, 2020 - scholar.archive.org
Patient-reported outcomes (PROs), such as symptoms, function, and other health-related
quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials …
quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials …
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the …
C Coens, M Pe, AC Dueck, J Sloan, E Basch… - The Lancet …, 2020 - europepmc.org
Patient-reported outcomes (PROs), such as symptoms, function, and other health-related
quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials …
quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials …
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the …
C Coens, M Pe, AC Dueck, J Sloan… - The Lancet …, 2020 - research.regionh.dk
Abstract Patient-reported outcomes (PROs), such as symptoms, function, and other health-
related quality-of-life aspects, are increasingly evaluated in cancer randomised controlled …
related quality-of-life aspects, are increasingly evaluated in cancer randomised controlled …
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the …
C Coens, M Pe, AC Dueck, J Sloan… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Patient-reported outcomes (PROs), such as symptoms, function, and other health-related
quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials …
quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials …
[PDF][PDF] International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials
C Coens, M Pe, AC Dueck, J Sloan, E Basch, M Calvert… - research.birmingham.ac.uk
EORTC received an unrestricted education grant from Boehringer Ingelheim GmbH 90 to
initiate this work and from Genentech, a member of the Roche Group, for 91 continuity …
initiate this work and from Genentech, a member of the Roche Group, for 91 continuity …
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the …
C Coens, M Pe, AAC Dueck, J Sloan, E Basch… - Lancet …, 2020 - difusion.ulb.ac.be
DI-fusion International standards for the analysis of quality-of-life... DIfusion ULB Recherche
avancée | Historique de recherche Mon DI-fusion | À propos de DI-fusion | Contact | Français …
avancée | Historique de recherche Mon DI-fusion | À propos de DI-fusion | Contact | Français …
[PDF][PDF] International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the …
Lancet Oncol, 2020 - kimia-pharma.co
Patient-reported outcomes (PROs), such as symptoms, function, and other health-related
quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials …
quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials …
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the …
C Coens, M Pe, AC Dueck… - The Lancet …, 2020 - scholarlypublications …
Patient-reported outcomes (PROs), such as symptoms, function, and other health-related
quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials …
quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials …